-
Andexanet alfa, sold
under the
brand name
Andexxa among others, is an
antidote for the
medications rivaroxaban and apixaban, when
reversal of anticoagulation...
-
reuptake inhibitors, and
nonsteroidal anti-inflammatory
drugs (NSAIDs).
Andexanet alfa is a US Food and Drug
Administration (FDA)
approved antidote for...
- for
DOACs are not as
widely studied,
idarucizumab (for dabigatran) and
andexanet alfa (for
factor Xa inhibitor) have been used in
clinical settings with...
-
authorisation for
Andexanet alfa (in EU: Ondexxya). In
April 2019 the
European Commission granted the
authorisation (approved)
Andexanet for the 28 countries...
-
sebelipase alfa (Kanuma), used to
treat lysosomal acid
lipase deficiency, and
andexanet alfa (Andexxa), used to stop life
threatening or
uncontrollable bleeding...
-
clinical trials for
andexanet alfa as an
antidote for
Factor Xa
inhibitors with few
adverse effects, and
started Phase III trials.
Andexanet alfa was approved...
-
antiplatelet medication. The
specific reversal agents idarucizumab and
andexanet alfa may be used to stop
continued intracerebral hemorrhage in people...
- v t e
AstraZeneca Products Acalabrutinib Anastrozole Andexanet alfa
Anifrolumab Asfotase alfa
Atenolol Benralizumab Bicalutamide Brompheniramine Budesonide...
- v t e
AstraZeneca Products Acalabrutinib Anastrozole Andexanet alfa
Anifrolumab Asfotase alfa
Atenolol Benralizumab Bicalutamide Brompheniramine Budesonide...
-
Arrillaga A,
Caronia C,
Rothburd L, ****he T, Hahn Y, et al. (2024). "Use of
Andexanet Alfa for
Factor Xa
Inhibitor Reversal in US
Verified Trauma Centers: A...
